Since lack of MIF predisposes to lung immaturity and the development of BPD, we tested whether the administration of the MIF agonist, MIF020, would ameliorate the pathologic effects of the BPD pulmonary phenotype. The gene discussed is MIF; the disease is bronchopulmonary dysplasia.